Practice Variability in Screening and Treating Pediatric Critical Illness Delirium: Survey
Related Experiment Video
Updated: Oct 14, 2025

Polar Histogram Visualization of Acute Stress Disorder Scale Scores for Comprehensive Clinical Assessment
Published on: December 6, 2024
Salim Aljabari1, Cara Carter2, Shahzad Waheed1
1Department of Child Health, University of Missouri-Columbia, Missouri, United States.
Insights
Pediatric delirium (PD) screening and treatment vary widely across US children's hospitals. The Cornell Assessment of Pediatric Delirium is common, but national guidelines are needed for consistent care.
Area of Science:
- Pediatric Critical Care Medicine
- Neuroscience
- Clinical Practice Guidelines
Background:
- Best practices for pediatric delirium (PD) screening and treatment remain undefined.
- Current recommendations are based on limited studies and adult data.
- Standardized approaches are lacking in pediatric critical care settings.
Purpose of the Study:
- To survey Pediatric Critical Care Medicine fellowship directors regarding PD screening and treatment.
- To identify current practices in large academic medical centers in the United States.
- To highlight the need for standardized national guidelines for pediatric delirium.
Main Methods:
- Cross-sectional survey of Pediatric Critical Care Medicine fellowship directors.
- Data collection on screening tools and pharmacologic treatments for PD.
- Analysis of reported practices across major US academic medical centers.
Main Results:
- Significant variability exists in PD screening and treatment protocols.
- The Cornell Assessment of Pediatric Delirium is the most frequently used screening tool.
- Quetiapine is the most commonly utilized pharmacologic agent for PD treatment.
Conclusions:
- There is a high degree of heterogeneity in pediatric delirium management.
- A national guideline is essential to standardize screening, prevention, and treatment of PD.
- Standardization will improve patient care and outcomes in pediatric critical care.
Abstract:
The best practice in pediatric delirium (PD) screening and treatment is still unknown. Current recommendations come from small studies and adult data. In this article, we surveyed the Pediatric Critical Care Medicine fellowship directors on PD screening and treatment practices in their centers. We reported high variability in the screening and treatment practices for PD in large academic medical centers in the United States. The Cornell Assessment of Pediatric Delirium tool is the most commonly used tool for screening, and quetiapine is the most commonly used pharmacologic agent. A national guideline on PD screening, prevention, and treatment is needed to standardize practice and provide guidance.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
11:05SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
Published on: February 6, 2021
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children